Preventing death of Barrett's cancer: Does frequent surveillance endoscopy do it?

American Journal of Medicine

Volumn 111, Issue 8 SUPPL. 1, 2001, Pages 137-141

  Sontag, Stephen J ^a,b,c  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c HINES VA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; PROTON PUMP INHIBITOR;

BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; CHEMOPROPHYLAXIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; ENDOSCOPY; GASTROESOPHAGEAL REFLUX; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL;

EID: 0035804026     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(01)00864-6     Document Type: Conference Paper

References (5)

1. Cancer statistics, 2001
2. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
3. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia
4. Epidemiology of columnar-lined esophagus and adenocarcinoma